Furosemide Given by Inhalation Ameliorates Acute Exacerbation of Asthma

Previous studies have suggested that inhaled furosemide may have a protective effect against a wide variety of bronchoconstrictor agents, but a therapeutic effect has not been established in acute exacerbation of asthma. The purpose of this study was to investigate whether inhaled furosemide would exhibit any therapeutic benefit in acute asthma. We conducted a double-blind, placebo-controlled, randomized study in 40 patients with acute mild or moderate exacerbation of asthma. All patients received intravenous (IV) aminophylline 250 mg for 90 min and IV hydrocortisone 100 mg at entry. After randomization, 3 patients were excluded from the final analysis. At 30 min after starting IV aminophylline, 20 patients were given inhaled furosemide 20 mg and 17 patients received normal saline as placebo-control. Both inhalations were given by a jet nebulizer. The baseline forced expiratory volume at 1 sec (FEV₁), peak expiratory flow rate (PEFR), and serum concentration of theophylline did not differ between the two groups. An increase in FEV₁ in the furosemide group by 28.2 ± 5.9% (mean ± SE) was noted at 60 min, and this was significantly higher than in the control group. PEFR at 60 min was also significantly higher in the furosemide group than in control group. We conclude that inhaled furosemide has a bronchodilator effect on mild to moderate exacerbation of asthma when it is used with IV theophylline. Inhaled furosemide may benefit certain acute asthma patients, especially those suffering complications from the adverse effects of β₂-agonists.     

100例严重烧伤死亡病例分析

目的 通过对两阶段烧伤死亡病人基本情况进行对比分析，以期探讨进一步提高烧伤救治率的有效措施。方法 总结近20年死亡烧伤病人100例，按前后各10年各50例病人分组(A和B两组)，对其病死率，烧伤面积，深度，致伤原因，院前治疗情况，入院时间，存活时间，吸入伤，气管切开，呼吸机与纤支镜的应用，手术例次，血液透析及死亡原因等进行对比分析。结果 两组烧伤严重程度无差别。致伤原因(多为火焰，爆炸和热液)和死亡原因(严重全身感染，多脏器衰竭和吸入性损伤)也类似，而近10年烧伤病死率明显降低，而入院时间明显滞后，但病人入院后存活时间明显延长，进一步分析发现近10年气管切开和呼吸机应用更加积极和应用广泛，纤支镜辅助检查和治疗增多，手术积极并例次增多，血液透析病例增多。结论 近lO年积极的气管切开，呼吸机和血液透析的应用和积极的手术治疗等综合治疗措施的改进对延长严重烧伤病人的存活期起着重要作用。     

Nitric oxide administration after the ventilator: evaluation of mixing conditions

Background: Because of the potential toxicity of nitric oxide (NO) and its oxidising product nitrogen dioxide (NO₂), any system for the delivery of inhaled NO must aim at stable and predictable levels of NO and as low concentrations as possible of NO₂.
Methods: In a laboratory set-up, we have evaluated mixing conditions in a system where NO is added after the ventilator with continuous flow. Mixing was studied by using carbon dioxide (CO₂) as a tracer gas since capnography has a short response time (360 ms) in comparison with measurements of NO with electrochemical fuel cells (response time of 18s). CO₂ (in volumes corresponding to an ideal mixture of 1,3 and 6%) was fed, after the ventilator, either into plain breathing tubing, into one or two soda lime absorbers, or into an empty and a soda lime-filled canister, at different ventilatory rates and different I: E ratios. Samples were drawn from the inspiratory limb close to the Y-piece. NO was added in the same way and in the same volume as the highest concentration of CO₂.
Results: CO₂ added to plain tubing resulted in peak levels up to five times the set levels, while addition to a mixing box with an empty and a soda lime-filled canister resulted in even mixing with gas concentrations close to the ideal. When NO was fed into plain tubing, low levels were measured at the Y-piece, indicating poor mixing. Gas supply to a mixing chamber resulted in even concentrations.
Conclusions: Even and predictable levels of NO can be obtained with continuous flow of NO to the inspiratory limb, after the ventilator, if a mixing chamber is used. To obtain adequate mixing, the volume of the mixing box should be greater than the tidal volume.     

代氟醚和安氟醚低流量循环密闭吸入全麻的临床观察

使用低流量循环密闭回路内注入给药法，比较１ＭＡＣ代氟醚和安氟醚各１４例维持全麻时循环动力苏醒情况和不良反应。结果；代氟醚在维持阶段对心血管系统的抑制较安氟醚为轻，很可能和代氟醚能使交感神经兴奋性增加有关。     

烧伤患者吸入性损伤和肺部感染的发生特点及其对死亡的影响

为了评价吸入性损伤和肺部感染的发生特点及其对死亡的影响，总结了我科近１４年住院治疗的热力烧伤患者９４０例，其中吸入性损伤７５例，轻度１５例，全部治愈，中度２５例，死亡１３例，死亡率为５２．０％，重度３５例，死亡３１例，死亡率为８８．６％。统计分析表明，合并吸入性损伤者６９．３％在密闭空间发生，同时伴有面部烧伤者达９６．０％。随着烧伤面积的增加，吸入性损伤发生率和肺部感染的发生率相应增加。有吸入性损伤肺部感染较无吸入性损伤肺部感染率为高（Ｐ＜０．０１），发生时间早。两组同等烧伤面积、深度、年龄患者，有吸入性损伤组发生死亡的危险比无吸入性损伤组大１７．２倍（Ｐ＜０．００１）。烧伤面积、深度和年龄相近，合并肺部感染者明显增加了死亡的机会（Ｐ＜０．００１）。     

病毒唑雾化吸入治疗上呼吸道感染临床疗效观察

选择89年2月至90年2月175例上呼吸道感染患儿,分为病毒唑雾化吸入组(61例).病毒唑全身给药组(53例)和对照组(61例).平均退热时间分别为30.01±.11,31.89±9.28,40.57±16.94小时.病毒唑组与对照组有非常显著性差异(p<0.01)但两病毒唑治疗组之间无显著性差异,并发现发病时间在一天内接受治疗者,退热时间明显短于超过一天之病例,且发病两天后治疗者与对照组已无显著差异(p<0.05).病毒唑全身用药组和对照组共有4例发展为支气管炎和肺炎,而雾化吸入组无,说明该治疗方法可以阻止病毒感染蔓延至下呼吸道.     

Acute inhalation toxicity of eugenol in rats

The acute toxicity of inhaled eugenol was assessed by exposure of three groups of five male and five female rats to a submicron aerosol of eugenol for 4 h followed by a 14-day observation period. A fourth group, also of five male and five female rats and exposed to air only under similar conditions, served as a control group for comparison. The three concentrations of eugenol to which the different groups were exposed were 2.58, 1.37 and 0.77 mg/l. The mass median aerodynamic diameters and geometric standard deviations of the aerosols were, respectively, 0.82 m (g 2.26), 0.88 m (g 2.05) and 0.9 m (g 1.87). Clinical signs observed during exposure consisted principally of moderately increased salivation and restlessness (indicative of irritation) and abnormal breathing patterns. The signs were graded, being less marked in animals exposed to the lower concentrations of eugenol. All three groups, exposed to high, medium and low levels of eugenol, lost weight overnight following exposure. Associated with the weight loss were marked reductions in food and water intake. The responses appeared to be largely independent of the concentration of eugenol inhaled, although there was some evidence of a graded effect on water intake. There was rapid recovery, with food and water consumption data comparable with control values throughout most of the remainder of the 14-day observation period. Also, by the end of the observation period, group mean body weights were comparable. Upon sacrifice and macroscopic examination of the animals, abnormalities were detected in the lungs only of a few animals: 3/10 control, 2/10 eugenol 2.58 mg/l, and 2/10 eugenol 0.77 mg/l. These consisted of dark red/red (raised) areas up to 4×4 mm. Such abnormalities are not uncommon in the lungs of laboratory maintained rats and their presence with equal incidence in control animals suggests that they are unlikely to be related to inhalation of eugenol. Lung weight to body weight ratio values for all groups were similar, providing no evidence of any persistent effect of eugenol on the lungs of the rats. Similarly, histopathological examination of the lung failed to reveal any treatment-related changes. A few incidental lesions present were considered spontaneous in origin and therefore of no toxicological importance.     

碱性成纤维细胞生长因子在治疗吸入性损伤中的疗效观察

目的：观察碱性成纤维细胞生长因子（BFGF）对吸入性损伤后气道粘膜及肺泡上皮的修复作用。方法：依据纤支镜结果将中、重度吸入性损伤分别随机分为BFGF治疗组与对照组。在相应时段进行纤支镜支气管肺泡灌洗术,摄像记录纤支镜所见及检测支气管肺泡灌洗液（BALF）中蛋白质含量、胶体渗透压（COP）与细胞分类计数。结果：在中、重度吸入性损伤中,其气道修复时间BFGF治疗组比对照组平均提前4．5天与3．3天;发生出血、气管支气管狭窄等并发症的机率平均降低64．65及31．9％。BFGF治疗组的BALF中总蛋白（TP）、白蛋白（ALb）、COP以及细胞总数、中性粒细胞、淋巴细胞数量均比对照组明显降低（P＜0．05）。结论：BFGF治疗中、重度吸入性损伤,能促进气道粘膜及肺泡上皮的修复。     

Soluble suppression of tumorigenicity-2 predicts pneumonia in patients with inhalation injury: Results of a pilot study

IntroductionSeveral mechanisms play a role in the development of pneumonia after inhalation injury. Our aim was to analyze whether higher concentrations of inflammatory markers or of biomarkers of epithelial injury are associated with a higher incidence of pneumonia in patients with inhalation injury.Material and methodsSecondary analysis of a single-center prospective observational cohort pilot study, performed over a two-year period (2015–2017) at the Burns Unit of the Plastic and Reconstructive Surgery Department of Vall d’Hebron University Hospital. All patients aged 18 with suspected inhalation injury undergoing admission to the Burns Unit were included. Plasma biomarkers of the lung epithelium (RAGE and SP-D), inflammation markers (IL6, IL8), and IL33, as well as soluble suppression of tumorigenicity-2 (sST2) levels, were measured within the first 24 h of admission.ResultsTwenty-four patients with inhalation injury were included. Eight (33.3%) developed pneumonia after a median of 7 (4–8) days of hospital stay. Patients with pneumonia presented higher plasma concentrations of sST2 (2853 [2356–3351] ng/mL vs 1352 [865–1839] ng/mL; p < 0.001), IL33 (1.95 [1.31–2.59] pg/mL vs 1.26 [1.07–1.45] pg/mL; p = 0.002) and IL8 (325.7 [221.6–430.0] pg/mL vs 174.1 [95.2–253.0] pg/mL; p = 0.017) on day 1 of inclusion. Plasma sST2 concentration in the first 24 h demonstrated excellent diagnostic accuracy for predicting the occurrence of pneumonia in patients with smoke inhalation (AUROC 0.929 [95%CI 0.818–1.000]). A cutoff point of ≥2825 ng/mL for sST2 had a sensitivity of 75% and a specificity of 100%. The risk ratio of pneumonia in patients with sST2 ≥ 2825 ng/mL was 7.14 ([95% CI 1.56–32.61]; p = 0.016).ConclusionsPlasma sST2 in the first 24 h of admission predicts the occurrence of pneumonia in patients with inhalation injury.     

Dose-dependent emergence of preneoplastic foci in rat livers after exposure to 2-nitropropane

Male and female Sprague-Dawley rats, 4–6 days old were exposed for 3 weeks (6 h/day, 5 days/week) to 2-nitropropane vapours of 0, 25, 40, 50, 80 and 125 ppm. One week later polychlorinated biphenyls (Clophen A50, 10 mg/kg body weight) were administered for promotion twice a week for 8 weeks. Thirteen weeks after starting the experiments the logarithms of the numbers of preneoplastic liver foci deficient in adenosine-5-triphosphatase were found to be linearly related to the exposure concentrations of 2-nitropropane. Male rats exhibited an approximately four times lower foci incidence than females.